Acid-Labile Subunit in Growth Hormone Excess and Deficiency in Adults: Evaluation of Its Diagnostic Value in Comparison with Insulin-Like Growth Factor (IGF)-I and IGF-Binding Protein-3.
- 1 January 2002
- journal article
- research article
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 49 (3), 379-386
- https://doi.org/10.1507/endocrj.49.379
Abstract
In serum, insulin-like growth factors (IGFs) are primarily present as a approximately 150 kDa ternary protein complex, which consists of IGFs, IGF binding protein-3 (IGFBP-3), and acid-labile subunit (ALS). Like IGF-I and IGFBP-3, serum levels of ALS depend on growth hormone (GH). To date, the diagnostic relevance of ALS in adult GH deficiency (GHD) has remained uncertain. To clarify the clinical utility of ALS measurement in adults, we measured serum ALS levels in patients with adult GHD or acromegaly. We also measured the levels of serum IGF-I and IGFBP-3 in these patients to compare the utility of ALS with IGF-I and IGFBP-3 as a marker of GH secretion. Serum ALS was measured by radioimmunoassay (RIA) kit, and serum IGF-I and IGFBP-3 were measured by immunoradiometric assay (IRMA) kits in 56 patients with adult GHD (adult-onset (AO)/child-onset (CO), 13/43) and 43 patients with acromegaly. Serum ALS levels were less than 5th percentile in 40 of 56 (71%) patients with adult GHD (32/43 (74%) for CO and 8/13 (62%) for AO), and more than 95th percentile in 38 of 43 (88%) patients with acromegaly, respectively. Serum IGF-I levels were less than -1.96 SD in 43 of 56 (77%) patients with adult GHD (35/43 (81%) for CO and 8/13 (62%) for AO) and more than +1.96 SD in 42 of 43 (98%) patients with acromegaly, respectively. Serum IGFBP-3 levels were less than -1.96 SD in 51 of 56 (91%) patients with adult GHD (42/43 (98%) for CO and 9/13 (69%) for AO) and more than +1.96 SD in 31 of 43 (72%) patients with acromegaly, respectively. These data suggested that measurement of ALS offers no advantage over measurements of serum IGF-I and IGFBP-3. Furthermore, our results indicate that serum IGFBP-3 is the most suitable marker of GH secretion for adult GHD, especially CO, while IGF-I may be the most useful in acromegaly.Keywords
This publication has 16 references indexed in Scilit:
- Effect of Severe Growth Hormone (GH) Deficiency due to a Mutation in the GH-Releasing Hormone Receptor on Insulin-Like Growth Factors (IGFs), IGF-Binding Proteins, and Ternary Complex Formation Throughout LifeJournal of Clinical Endocrinology & Metabolism, 1999
- The Acid-Labile Subunit of Human Ternary Insulin-Like Growth Factor Binding Protein Complex in Serum: Hepatosplanchnic Release, Diurnal Variation, Circulating Concentrations in Healthy Subjects, and Diagnostic Use in Patients with Growth Hormone DeficiencyJournal of Clinical Endocrinology & Metabolism, 1998
- The Diagnosis of Growth Hormone Deficiency in Children and AdultsEndocrine Reviews, 1998
- Acid-Labile Subunit of Human Insulin-Like Growth Factor-Binding Protein Complex: Measurement, Molecular, and Clinical EvaluationJournal of Clinical Endocrinology & Metabolism, 1997
- Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and FunctionsEndocrine Reviews, 1997
- Clinical Utility of Insulin-Like Growth Factor-I (IGF-I) and IGF Binding Protein-3 Levels in the Diagnosis of GH Deficiency (GHD) During Childhood.Endocrine Journal, 1996
- Clinical aspects of growth hormone deficiency in adultsEndocrine Reviews, 1995
- Diagnosis of growth hormone deficiency in adultsThe Lancet, 1994
- Circulating Levels and Molecular Distribution of the Acid-Labile (α) Subunit of the High Molecular Weight Insulin-Like Growth Factor-Binding Protein Complex*Journal of Clinical Endocrinology & Metabolism, 1990
- A Specific Radioimmunoassay for the Growth Hormone (GH)-Dependent Somatomedin-Binding Protein: Its Use for Diagnosis of GH DeficiencyJournal of Clinical Endocrinology & Metabolism, 1990